Apogee Therapeutics, Common Stock Probability of Future Stock Price Finishing Over 48.28
| APGE Stock | 45.15 0.45 1.01% |
Apogee |
Apogee Therapeutics, Target Price Odds to finish over 48.28
The tendency of Apogee Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 48.28 or more in 90 days |
| 45.15 | 90 days | 48.28 | about 82.72 |
Based on a normal probability distribution, the odds of Apogee Therapeutics, to move over 48.28 or more in 90 days from now is about 82.72 (This Apogee Therapeutics, Common probability density function shows the probability of Apogee Stock to fall within a particular range of prices over 90 days) . Probability of Apogee Therapeutics, price to stay between its current price of 45.15 and 48.28 at the end of the 90-day period is about 11.82 .
Given the investment horizon of 90 days Apogee Therapeutics, has a beta of 1.0. This suggests Apogee Therapeutics, Common market returns are highly-sensitive to returns on the market. As the market goes up or down, Apogee Therapeutics, is expected to follow. Additionally Apogee Therapeutics, Common has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Apogee Therapeutics, Price Density |
| Price |
Predictive Modules for Apogee Therapeutics,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apogee Therapeutics,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Apogee Therapeutics, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Apogee Therapeutics, is not an exception. The market had few large corrections towards the Apogee Therapeutics,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Apogee Therapeutics, Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Apogee Therapeutics, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 4.75 | |
Ir | Information ratio | -0.05 |
Apogee Therapeutics, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Apogee Therapeutics, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Apogee Therapeutics, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Apogee Therapeutics, generated a negative expected return over the last 90 days | |
| Apogee Therapeutics, has high historical volatility and very poor performance | |
| Apogee Therapeutics, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (83.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Apogee Therapeutics, generates negative cash flow from operations | |
| Apogee Therapeutics, has a frail financial position based on the latest SEC disclosures | |
| Over 88.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Guggenheim lifts Apogee Therapeutics shares target on strategy |
Apogee Therapeutics, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Apogee Stock often depends not only on the future outlook of the current and potential Apogee Therapeutics,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Apogee Therapeutics,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25 M | |
| Cash And Short Term Investments | 395.5 M |
Apogee Therapeutics, Technical Analysis
Apogee Therapeutics,'s future price can be derived by breaking down and analyzing its technical indicators over time. Apogee Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Apogee Therapeutics, Common. In general, you should focus on analyzing Apogee Stock price patterns and their correlations with different microeconomic environments and drivers.
Apogee Therapeutics, Predictive Forecast Models
Apogee Therapeutics,'s time-series forecasting models is one of many Apogee Therapeutics,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Apogee Therapeutics,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Apogee Therapeutics,
Checking the ongoing alerts about Apogee Therapeutics, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Apogee Therapeutics, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Apogee Therapeutics, generated a negative expected return over the last 90 days | |
| Apogee Therapeutics, has high historical volatility and very poor performance | |
| Apogee Therapeutics, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (83.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Apogee Therapeutics, generates negative cash flow from operations | |
| Apogee Therapeutics, has a frail financial position based on the latest SEC disclosures | |
| Over 88.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Guggenheim lifts Apogee Therapeutics shares target on strategy |
Check out Apogee Therapeutics, Backtesting, Apogee Therapeutics, Valuation, Apogee Therapeutics, Correlation, Apogee Therapeutics, Hype Analysis, Apogee Therapeutics, Volatility, Apogee Therapeutics, History as well as Apogee Therapeutics, Performance. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apogee Therapeutics,. If investors know Apogee will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apogee Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.43) | Return On Assets (0.19) | Return On Equity (0.26) |
The market value of Apogee Therapeutics, is measured differently than its book value, which is the value of Apogee that is recorded on the company's balance sheet. Investors also form their own opinion of Apogee Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Apogee Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apogee Therapeutics,'s market value can be influenced by many factors that don't directly affect Apogee Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apogee Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Apogee Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apogee Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.